Investment banks, deals & M&A
Writer

Charles Fenwick

Charles Fenwick writes for Merja Review and other Independent Journal publications, covering M&A, activist stakes and investment banks and earnings and corporate announcements. Reporting under this byline is prepared by the Independent Journal editorial desk from primary sources, with AI assistance, and reviewed under our editorial policy.

7 articles

Schedule 13D

Schedule 13D/A From Independence Energy Aggregator Lands

Independence Energy Aggregator L.P. filed a Schedule 13D/A on Oct. 13. What an amendment signals, plus two same-day 8-Ks from Sadot and VisionWave worth tracking.

3 min read
Glass office building facade
Guide

Hart-Scott-Rodino merger review explained: HSR filings

Hart-Scott-Rodino merger review explained: who files, the 30-day and 15-day waiting periods, second requests, early termination and which agency reviews a deal.

8 min read
Drilling rig at an oil field, representing the energy services sector in which KLX operates
Schedule 13D

Schedule 13D: Cross Ocean Holds 21.3% of KLX Energy After Rights Deal

Cross Ocean Partners reported 22.5 million KLX Energy shares, 21.3%, after swapping 2030 notes in a $125 million rights offering, with a board seat right.

3 min read
8-K filings

Waste Energy's bylaw 8-K: what a 13D filing would add

Waste Energy Corp. filed an 8-K on Oct. 5 under Item 5.03 for charter or bylaw changes. Here is what the filing shows, what it omits and what to watch next.

3 min read
Stack of corporate filing documents on a desk
8-K filings

Outdoor Holding 8-K: Texas Conversion, Not a Merger 8-K

Outdoor Holding's Oct. 2 8-K reports a Delaware-to-Texas conversion approved 74.1M to 11.0M, a move of headquarters to Dallas and heavy opposition to one director.

3 min read
Schedule 13D

Tether's Schedule 13D Amendment Lifts Gold.com Stake to 11.8%

A May 2026 Schedule 13D/A shows Tether-linked entities hold 11.8% of Gold.com after a $150 million purchase, with a board seat and intent to exercise control.

3 min read
Mergers

Avanos Merger 8-K: $25 a Share Cash Deal With AIP-Backed Buyer

Avanos Medical's April 2026 merger 8-K details a $25 per share cash sale to a buyer backed by American Industrial Partners, with a $37.5 million breakup fee.

3 min read